Prader-Willi综合征的治疗进展

doi:10.11852/zgetbjzz2019-1166

中国儿童保健杂志 ›› 2020, Vol. 28 ›› Issue (7): 752-755.DOI: 10.11852/zgetbjzz2019-1166

Prader-Willi综合征的治疗进展

王欣, 曲书强

哈尔滨医科大学附属第二医院儿内科,黑龙江哈尔滨 150086

收稿日期:2019-10-01 发布日期:2020-07-10 出版日期:2020-07-10
通讯作者: 曲书强,E-mail:qsq1962@aliyun.com
作者简介:王欣(1994-),女,黑龙江人,硕士研究生,主要研究方向为小儿呼吸、新生儿。

Advances on the treatment of Prader-Willi syndrome

WANG Xin, QU Shu-qiang

Department of Neonatal Pediatrics,the Second Affiliated Hospital,Harbin Medical University,Harbin,Heilongjiang 150086,China

Received:2019-10-01 Online:2020-07-10 Published:2020-07-10
Contact: QU Shu-qiang,E-mail:qsq1962@aliyun.com.

摘要/Abstract

摘要： Prader-Willi综合征是由父源的15q11.2-13区域的印记基因缺陷所导致的复杂的多系统异常。其特征是内分泌、代谢、认知、行为和精神症状相结合,相关的呼吸障碍对患者的日常生活具有高度破坏性,也是最常见的死亡原因。患者为了获取食物可表现出强迫性行为,进而出现病态肥胖,这对社会功能和生活质量产生了极其有害的影响。因此,合理、有效的治疗在极大程度上可以改善患儿的预后。

关键词: Prader-Willi综合征, 肥胖, 睡眠障碍, 呼吸困难

Abstract: Prader-willi syndrome is a complex multisystem anomaly caused by imprinted genetic defects in the patent-derived 15q11.2-13 region,which is characterized by a combination of endocrine,metabolic,cognitive,behavioral and psychiatric symptoms.Associated respiratory disorders are highly disruptive to patients' daily lives and are the most common cause of death.Compulsive behavior in order to obtain food can lead to morbid obesity,which has extremely detrimental effects on social function and quality of life.Therefore,reasonable and effective treatment can greatly improve the prognosis of children.

Key words: Prader-Willi syndrome, obesity, dyssomnia, expiratory dyspnea, treatment

中图分类号:

R725.9

王欣, 曲书强. Prader-Willi综合征的治疗进展[J]. 中国儿童保健杂志, 2020, 28(7): 752-755.

WANG Xin, QU Shu-qiang. Advances on the treatment of Prader-Willi syndrome[J]. journal1, 2020, 28(7): 752-755.

参考文献

[1] Angulo MA,Butler MG,Cataletto ME.Prader-Willi syndro me:a review of clinical,genetic,and endocrine findings[J].J Endocrinol Invest,2015,38(12):1249-1263.
[2] Carter CS.Oxytocin pathways and the evolution of human behavior[J].Annu Rev Psychol,2014,65:17-39.
[3] Numan M,Young LJ.Neural mechanisms of mother-infant bonding and pair bonding:Similarities,differences,and broader implications[J].Horm Behav,2016,77:98-112.
[4] Tauber M,Boulanouar K,Diene G,et al.The use of oxytocin to improve feeding and social sills in infants with Prader Willi Syndrome[J].Pediatrics,2017,139(2).doi:10.1542.
[5] Schaaf CP,Gonzalez-Garay ML,Xiao F,et al.Truncating mu tations of MAGEL2 cause Prader-Willi phenotypes and autism[J].Nat Genet,2013,45(11):1405-1408.
[6] Butler MG.Singlegene and syndromic causes of obesity:Illustrative examples[J].Prog Mol Biol Transi Sci,2016,140:1-45.
[7] Haliloglu B,Bereket A.Central control of energy metabolism and hypothalamic obesity pediatric obesity[J].Springer,2018,30:27-42.
[8] Lee JM,Shin J,Kim S,et al.Rapid-onset obseity with hypoventilation,hypothalamic,autonomic dysregulation,and neuroendocrine tumors (ROHHADNET) syndrome [J].BioMed Res Int,2018.doi:10.1155.
[9] McCandless SE,Yanovski JA,Miller G,et al.Effects of Me tAP2 inhibition on hyperphagia and body weight in Prader-Willi syndrome:a randomized,double-blind,placebocontrolled trial[J].Diabetes Obes Metab,2017,19(12):1751-1761.
[10] Griggs JL,Mathai ML,Sinnayah P.Caralluma fimbriata extract activity involves the 5-HT2c receptor in PWS Snord116 deletion mouse model[J].Brain Behav,2018,8(12).doi:10.1002.
[11] Polex-Wolf J,Lam BY,Larder R,et al.Hypothalamic loss of Snord116 recapitulates the hyperphagia of Prader-Willi syndrome[J].J Clin Investig,2018,128(3):960-969.
[12] Zhang Z,Shen M,Gresch PJ,et al.Oligonucleotide-induced alternative splicing of serotonin 2C receptor reduces food intake[J].EMBO Mol Med,2016,8(8):878-894.
[13] Knani I,Earlay BJ,Udis S,et al.Targeting the endocannabinoid/CB1 receptor system for treating obesity in Pradere-Willi syndrome[J].Mol Metab,2016,5(12):1187-1199.
[14] Reus L,Pelzer BJ,Otten BJ,et al.Growth hormone combined with child-specific motor training improves motor development in infants with Prader-Willi syndrome:a randomized controlled trial[J].Res Dev Disabil,2013,34(10):3092-3103.
[15] Mahabier EF,Donze SH,Damen L,et al.Improved mental and motor development during 3 years of GH treatment in very young children with prader-willi syndrome[J].J Clin Endocrinol Metab,2018,103(10):3714-3719.
[16] Bakker NE,Kuppens RJ,Festen DA,et al.Eight years of growth hormone treatment in children with Prader-Willi syndrome:maintaining the positive effects[J].J Clinical Endocrinol Metab,2013,98(10):4013-4022.
[17] Kuppens RJ,Bakker NE,Siemensma EP,et al.Beneficialeffects of GH in young adults with Prader-Willi syndrome:a 2-year crossover trial[J].J Clinv Endocrinol Metab,2016,101(11):4110-4116.
[18] Pavone M,Caldarelli V,Khirani S,et al.Sleep disordered breathing in patients with Prader-Willi syndrome:a multicenter study[J].Pediatr pulmonol,2015,50(12):1354-1359.
[19] Sedky K,Bennett DS,Pumariega A,et al.Prader-Willi syndrome and obstructive sleep apnea:co-occurrence in the pediatric population[J].J Clin Sleep Med,2014,10(4):403-409.
[20] Ghergan A,Coupaye M,Attali V,et al.Prevalence and phenotype of sleep disorders in 60 adults with Prader-Willi syndrome[J].Sleep,2017,40(12).doi:10.1093.
[21] Tan HL,Urquhart DS.Respiratorycomplications in children with Prader Willi syndrome[J].Paediatric Respiratory Reviews,2017,22:52-59.
[22] Berini J,Spica Russotto V,Castelnuovo P,et al.Growth hormone therapy and respiratory disorders:long-term follow-up in PWS children[J].J Clin Endocrinol Metab,2013,98(9):1516-1523.
[23] Dauvilliers Y,Bassetti C,Lammers GJ,et al.Pitolisant versus placebo or modafinil in patients with narcolepsy:a double-blind,randomised trial[J].Lancet Neurol,2013,12(11):1068-1075.
[24] Stark H.Histamine H3 receptor antagonists on sleep disturbance[R].9th International Prader-Willi-Syndrome Organisation Conference (IPWSO) Scientific Abstract Booklet,2017,5(34):1-26.
[25] Krishnadas R,Cooper SA,Nicol A,et al.Brain-stem serotonin transporter availability in maternal uniparental disomy and deletion Prader Willi syndrome[J].Br J Psychiatry,2018,212(1):57-58.
[26] Matarazzo1 V,Caccialupi L,Schaller F,et al.Necdin shapes serotonergic development and SERT activity modulating breathing in a mouse model for Prader-Willi syndrome[J].Elife,2017.doi:10.7554.
[27] Crunkhorn S.Genetic disorders:Steps towards epigenetic th erapy for PWS[J].Nat Rev Drug Discov,2017,16(2):85.

Prader-Willi综合征的治疗进展

Advances on the treatment of Prader-Willi syndrome

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	王雯雷, 张俊, 厚磊, 张荣, 夏木斯叶·木依都力, 董言, 者炜, 沙吾拉西·热加甫, 方萍, 阿迪拉·苏力旦. 新疆7～17岁儿童青少年超重肥胖和血压关系的关联研究[J]. 中国儿童保健杂志, 2024, 32(9): 953-957.
[2]	毛广惠, 王丹, 李丽丽, 季忆婷, 王琪玉, 冯晨霞, 赵晓燕, 何璐, 蔡世忠, 陈艳. 学龄期注意缺陷多动障碍儿童的人体成分分析[J]. 中国儿童保健杂志, 2024, 32(9): 1029-1033.
[3]	鹿文英, 柏品清, 徐划萍, 任亚萍, 胡卉, 解辉. 运动及行为干预改善儿童超重和肥胖效果评价[J]. 中国儿童保健杂志, 2024, 32(8): 832-837.
[4]	周琼, 刘海波, 胡必梅, 郭玉清. 母亲喂养方式、婴幼儿饮食行为及气质对儿童超重肥胖的影响[J]. 中国儿童保健杂志, 2024, 32(8): 850-855.
[5]	陈瑜洁, 李晓南. 行为干预在儿童肥胖管理中的应用进展[J]. 中国儿童保健杂志, 2024, 32(8): 875-880.
[6]	刘璐洁, 徐东, 尹春燕, 肖延风. 儿童肥胖代谢组学的研究进展[J]. 中国儿童保健杂志, 2024, 32(8): 881-885.
[7]	邹亦飞, 杨一卓, 郭建军. 儿童肌少症评估方法研究进展[J]. 中国儿童保健杂志, 2024, 32(8): 891-896.
[8]	李雪峰, 刘亚昆, 郎静, 魏守刚. 基于随机森林算法探讨血液中营养与代谢相关指标在1~6岁儿童肥胖中的相对重要性[J]. 中国儿童保健杂志, 2024, 32(6): 625-630.
[9]	汪洁, 薛永珍, 徐铭, 陈为菊, 尤娟娟, 胡艳艳. 肥胖儿童血清鸢尾素与内分泌代谢指标的相关性[J]. 中国儿童保健杂志, 2024, 32(6): 668-671.
[10]	李宗芹, 王念蓉, 申量, 肖宵, 王丽. 婴儿体成分与超重/肥胖的一致性分析[J]. 中国儿童保健杂志, 2024, 32(6): 672-677.
[11]	金彩娥, 李高强, 杨庆伟, 杨顺玲, 王益民. 蒙自市7～17岁儿童青少年超重、肥胖和血压偏高现状分析[J]. 中国儿童保健杂志, 2024, 32(4): 384-388.
[12]	邓莎莎, 孟玉梅, 孙榕伯, 沈玲玲, 孔锐. 苏州市学龄前儿童超重与肥胖流行现况及影响因素[J]. 中国儿童保健杂志, 2024, 32(4): 389-394.
[13]	陈艳琳, 万梓豪, 候芳, 李丽. 学龄前儿童家长体重感知干预效果评价[J]. 中国儿童保健杂志, 2024, 32(4): 401-404.
[14]	胡彩霞, 邬天凤, 陈华, 王森, 陈亦晨, 盛嘉懿, 孙良红, 曲晓滨, 周弋, 柏品清. 母亲孕期增重及孕前体质量指数对学龄儿童超重肥胖的影响[J]. 中国儿童保健杂志, 2024, 32(3): 248-254.
[15]	宗心南. 我国儿童体格发育调查研究的历史回顾、成绩、问题与展望[J]. 中国儿童保健杂志, 2024, 32(11): 1163-1168.